NewLeaf Symbiotics
PrivateLast Round
Series D
Dec 19, 2023
Total Funding Raised
$141M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NewLeaf Symbiotics is an agricultural biotechnology company that develops and commercializes sustainable agricultural products based on beneficial bacteria to help farmers fight plant disease and increase crop yields.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NewLeaf Symbiotics Comps
Public and private peers based on sector, stage, and business model.
NewLeaf Symbiotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 19, 2023 | ||||
| Series D | Dec 1, 2020 | ||||
| Series D | Feb 24, 2020 | ||||
| Series C | Sep 7, 2017 | ||||
| Series B | Sep 17, 2014 | ||||
Series A | Jan 10, 2013 |
Key People
Founding team and executive leadership
NewLeaf Symbiotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RockPort Capital Partners | Series D, Series A, Series C, Series B |
| Open Prairie | Series A, Series C, Series B |
| Open Prairie Ventures | Series C, Series B, Series A |
| Re:food | Series D |
| The Yard Ventures | Series C |
| Lewis & Clark Partners | Series C |
| Lewis & Clark Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Launching a new biostimulant for vegetable transplants on July 1, 2026.
- Apr 2, 2026
CEO spoke at the Top Producer Summit on science and innovation.
NewLeaf Symbiotics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NewLeaf Symbiotics's valuation, stock price, and market status.
